Paper Details

  1. Home
  2. Paper Details

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma.

Author: GaoTian-Xiao, HuangJia-Jia, JiangWen-Qi, LiZhi-Ming, SunPeng, SunXiao-Qing, WangCai-Qin, WangYu, WuKe

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A combination of etoposide and everolimus was more effective than etoposide alone in treating Non-Hodgkin lymphoma.
Paper Details　
Original Abstract of the Article :
Patients with Non-Hodgkin lymphoma (NHL) treated by conventional chemotherapeutic drugs usually require a long recovery period. However, metronomic combination chemotherapy (MCC) enhances therapeutic efficacy and decreases side effects in the treatment of NHL. In this study, we tested and compared t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712471/

データ提供：米国国立医学図書館（NLM）

A New Approach to Non-Hodgkin Lymphoma: Metronomic Chemotherapy

Navigating the vast desert of cancer research, I've witnessed a constant evolution in treatment strategies. This study focuses on a novel approach for treating Non-Hodgkin lymphoma (NHL): metronomic combination chemotherapy (MCC). This innovative method employs low-dose chemotherapy drugs delivered in a continuous, metronome-like fashion, aiming to maximize therapeutic efficacy while minimizing side effects.

A Different Rhythm for Chemotherapy

Imagine a desert traveler navigating challenging terrain, constantly adjusting their pace to optimize their journey. MCC operates on a similar principle, adjusting the timing and dosage of chemotherapy drugs to achieve optimal results. This novel approach deviates from traditional high-dose chemotherapy regimens, aiming for a more sustainable and less disruptive treatment.

A Promising New Frontier in Cancer Treatment

The study reveals the potential benefits of MCC in treating NHL, demonstrating its ability to effectively control tumor growth while reducing the burden of side effects. Think of it this way: in the vast desert of cancer research, MCC represents a new oasis, offering a more comfortable and effective path to recovery.

Dr.Camel's Conclusion

This research holds great promise for the future of cancer treatment. MCC offers a refreshing new perspective on chemotherapy, promising to improve patient outcomes and quality of life. Just as a well-timed rhythm can guide a traveler through the desert, MCC provides a new and effective rhythm for cancer treatment.
Date :
  1. Date Completed 2020-08-14
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

31218841

DOI: Digital Object Identifier

PMC6712471

Related Literature

Article Analysis
・Side Effects of everolimus
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.